Curia Capacity Update October 2024: Fill/Finish

Partnering with Curia as a fill-finish provider offers a wealth of expertise and reliable support throughout every stage of your product’s lifecycle. With extensive experience in sterile fill-finish manufacturing for injectable therapeutics across multiple modalities, Curia Drug Product is a strategic partner capable of supporting projects from pre-clinical development through to commercial launch and sustained supply.

Curia’s ongoing capacity expansions are set to enhance availability and reinforce our capabilities, enabling us to meet the increasing demands of the market. Our advanced facilities will offer expanded support for liquid and lyophilized vials, prefilled syringes (PFS), and cartridges, ensuring we continue to deliver the highest quality and adaptability for a wide range of injectable products.